Tonix's Tonmya received FDA approval, marking the first new fibromyalgia therapy in 15 years and driving a post-market stock ...

IHF offers exposure to large-cap healthcare, AI-driven growth, and demographic trends, with a recent dip creating a strong ...

Healthcare Opportunities Fund offers a compelling way to play the healthcare sector. Read here for an analysis of THQ CEF.

I've made costly mistakes in my REIT investing journey, lessons that reshaped my approach and strategy. Learn why smarter ...

Dole trades at fair value with modest growth, high debt, and slim margins, limiting upside despite deleveraging and stable ...

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Powell Industries (POWL) offers 50% upside potential. Learn about growth in Electric Utility, strategic acquisitions, and ...

Value Line's digital growth offsets print decline, ensuring steady dividends amid modest revenue. Read here for an analysis ...

Floor & Decor's niche business model, growth potential, and strong management make it a standout in the flooring market. See ...

Hope Bancorp's loan growth outlook in markets in Hawaii, California, and New York is slightly negative. See why a hold rating ...

Hilton’s asset-light model, global reach, and strong Q2 2025 results support steady growth despite macro pressures and ...

Blue Owl Capital drives AUM and fee growth through strategic acquisitions, global expansion, and rising dividends. Check out ...